Hecoria (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Hecoria drug offered from Novartis Pharmaceuticals Corporation. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | Tacrolimus |
SUBSTANCE NAME: | TACROLIMUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-20 |
END MARKETING DATE: | 0000-00-00 |
Hecoria HUMAN PRESCRIPTION DRUG Details:
Item Description | Hecoria from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2011-12-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0616_99b9a738-b0f7-4213-b15f-a9d3f7e82570 |
PRODUCT NDC: | 0078-0616 |
APPLICATION NUMBER: | ANDA065461 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers: